Wall Street Bets Lilly’s GLP-1 Portfolio, Missed $1T
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Identify quick wins and smarter choices that trim expenses without sacrificing essentials, helping you keep more of your income.
23,072 articlesInvestors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Meta Platforms is gaining momentum in July 2026 as advertisers lean into AI-powered targeting. This piece explains wh...
American Express reveals plans for a 55-floor headquarters at the World Trade Center site, targeting 2031 completion ...
China unveils a restrained 2026 growth target of 4.5% to 5%, marking the lowest goal in decades as policymakers weigh...
A fresh examination of the innovations powering U.S. military dominance and how investors are pricing defense names i...
A growing wave of workers relies on AI to interpret messages and draft replies from supervisors, a trend that could s...
What started as a bold direct investment in OpenAI has bloomed into a multi-billion payoff for Michigan’s public endo...
KeyBanc boosts Okta's target to $103 from $95, citing a brighter security spending outlook and the central role of id...
Vitalik Buterin announces a structural reset for the Ethereum Foundation to reduce selling pressure and sharpen gover...
Alphabet and Meta are steering through a redefining ad market shaped by AI investment. This piece compares valuation,...
Archer Aviation advances toward FAA Type Certification, with a looming Texas governance vote and a quarterly report t...
A major software conglomerate trading at a low forward multiple reports a record quarter, driving renewed investor in...